-
CFF Awards TB Alliance $5.1M to Develop Therapies for NTM Infections
TB Alliance will use its $5.1 million award to develop potential therapies for treating multidrug-resistant NTM infections in cystic fibrosis patients. Learn more about this here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.